Sky Century Investment (SKYI) Payables (2013 - 2026)

Sky Century Investment's (SKYI) quarterly Payables came in at $182432.0 in Q2 2026, down 27.56% year-on-year from $251847.0 in Q2 2025, and down 28.95% on a QoQ basis from $256777.0 in Q1 2026.

Sky Century Investment (SKYI) Payables (2013 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 5 years of Payables data on file, last reported at $182432.0 in Q2 2026.

  • On a quarterly basis, Payables fell 27.56% year-over-year to $182432.0 in Q2 2026; TTM through May 2026 was $182432.0, a 27.56% decrease from a year earlier, with the FY2025 full-year figure at $248794.0, up 31.71% from the prior year.
  • Payables for Q2 2026 stood at $182432.0, down from $256777.0 in the prior quarter.
  • Over the last five years, Payables for SKYI reached as high as $258140.0 in Q4 2025 and fell as low as $182432.0 in Q2 2026.
  • Historically, Payables has averaged $225269.6 across 3 years, with a median of $248794.0 in 2025.
  • On a YoY basis, Payables climbed as much as 35.15% in 2026 and fell as far as 27.56% in 2026.
  • Year by year, Payables stood at $188897.0 in 2024, then soared by 36.66% to $258140.0 in 2025, then dropped by 29.33% to $182432.0 in 2026.
  • Per Business Quant data, the three most recent Payables figures were $182432.0 in Q2 2026, $256777.0 in Q1 2026, and $258140.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 4.96 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.60 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 731.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 498.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 8.82 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.75 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 773.00 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 372.00 Mn
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 182,432.00

Historic Data

Download Data
DateValue
May 31, 2026 182,432.00
Feb 28, 2026 256,777.00
Nov 30, 2025 258,140.00
Aug 31, 2025 248,794.00
May 31, 2025 251,847.00
Feb 28, 2025 190,000.00
Aug 31, 2024 188,897.00
Aug 31, 2014 14,880.00
May 31, 2014 6,450.00
Feb 28, 2014 2,000.00
Nov 30, 2013 2,300.00
Aug 31, 2013 2,500.00
May 31, 2013 4,000.00